Thanks to a full portfolio of medical writing services, our clients have access to start-to-finish support for every clinical research text, including expertly crafted reports in compliance with ICH human use guidelines, clinical trial protocols, regulatory documentation, and other submission documents all the way to abstract and manuscript completion. Our oncology medical writers consult with your team—as well as therapeutic experts, researchers and academics—to develop a sophisticated and in-depth understanding of your program. Writing services vary by your needs and can include:

  • Drug development plans
  • Investigator brochures
  • Protocol synopses, full protocols and protocol amendments
  • Informed Consent Form (ICF)
  • Clinical study reports (Phase I and II)
  • Interim data summaries
  • FDA pre-IND meeting request and briefing packages
  • Investigational new drug application (IND) (technical writing for all IND Modules 1-5)
  • Abstracts and manuscripts

Ask us how you can get your clinical plan started today.

Need help with your model selection? Contact TD2 to get more information about our murine models available for immediate use.

Contact Us Now
You may also be interested in
Clinical Technology and Next-Generation Oncology Trials Read the Post Clinical The Clinical Trial Process Continues Amid COVID-19 Read the Post Clinical The Trends Behind Successful Cancer Treatments Read the Post